The guanine nucleotide exchange factors Trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma

American Journal of Pathology

Volumn 173, Issue 6, 2008, Pages 1828-1838

  Salhia, Bodour ^a,b   Tran, Nhan L ^b   Chan, Amanda ^c   Wolf, Amparo ^a   Nakada, Mitsutoshi ^d   Rutka, Fiona ^a   Ennis, Matthew ^b   McDonough, Wendy S ^b   Berens, Michael E ^b   Symons, Marc ^c,e   Rutka, James T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c Feinstein Institute for Medical Research at North Shore Long Island Jewish Health System ^*  (United States)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR ECT2; GUANINE NUCLEOTIDE EXCHANGE FACTOR TRIO; GUANINE NUCLEOTIDE EXCHANGE FACTOR VAV3; GUANOSINE TRIPHOSPHATASE; RAC1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

EID: 57149120776     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080043     Document Type: Article

References (54)

1. Christofori G: New signals from the invasive front. Nature 2006, 441:444-450
2. Demuth T, Reavie LB, Rennert JL, Nakada M, Nakada S, Hoelzinger DB, Beaudry CE, Henrichs AN, Anderson EM, Berens ME: MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Mol Cancer Ther 2007, 6:1212-1222
3. Yamaguchi H, Wyckoff J, Condeelis J: Cell migration in tumors. Curr Opin Cell Biol 2005, 17:559-564
4. Raftopoulou M, Hall A: Cell migration: Rho GTPases lead the way. Dev Biol 2004, 265:23-32
5. Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M: Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005, 24:7821-7829
6. Chuang YY, Tran NL, Rusk N, Nakada M, Berens ME, Symons M: Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res 2004, 64:8271-8275
7. Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, Kwan A, Rutka JT: Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 2005, 65:8792-8800
8. Symons M, Settleman J: Rho family GTPases: more than simple switches. Trends Cell Biol 2000, 10:415-419
9. Jaffe AB, Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005, 21:247-269
10. Lu M, Kinchen JM, Rossman KL, Grimsley C, Hall M, Sondek J, Hengartner MO, Yajnik V, Ravichandran KS: A steric-inhibition model for regulation of nucleotide exchange via the Dock180 family of GEFs. Curr Biol 2005, 15:371-377
11. Rossman KL, Der CJ, Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005, 6:167-180
12. Gómez del Pulgar T, Benitah SA, Valeron PF, Espina C, Lacal JC: Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 2005, 27:602-613
13. Tran NL, McDonough WS, Savitch BA, Fortin SP, Winkles JA, Symons M, Nakada M, Cunliffe HE, Hostetter G, Hoelzinger DB, Rennert JL, Michaelson JS, Burkly LC, Lipinski CA, Loftus JC, Mariani L, Berens ME: Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-{kappa}B and correlate with poor patient outcome. Cancer Res 2006, 66:9535-9542
14. Elbashir SM, Lendeckel W, Tuschl T: RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15:188-200
15. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990, 82:1107-1112
16. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M: Cell migration and invasion assays. Methods 2005, 37:208-215
17. Berens M, Rief M, Loo M, Giese A: The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 1994, 12:405-415
18. Jung S, Ackerley C, Ivanchuk S, Mondal S, Becker LE, Rutka JT: Tracking the invasiveness of human astrocytoma cells by using green fluorescent protein in an organotypical brain slice model. J Neurosurg 2001, 94:80-89
19. Jung S, Hinek A, Tsugu A, Hubbard SL, Ackerley C, Becker LE, Rutka JT: Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia 1999, 25:179-189
20. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, Chen X, Lee CC, Lorenzi MV, Ohara N, Miki T: Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem 2004, 279:7169-7179
21. Quinn MT, Evans T, Loetterle LR, Jesaitis AJ, Bokoch GM: Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components. J Biol Chem 1993, 268:20983-20987
22. Vichai V, Kirtikara K: Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 2006, 1:1112-1116
23. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T: Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol 1999, 147:921-928
24. Solski PA, Wilder RS, Rossman KL, Sondek J, Cox AD, Campbell SL, Der CJ: Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation. J Biol Chem 2004, 279:25226-25233
25. Blangy A, Vignal E, Schmidt S, Debant A, Gauthier-Rouviere C, Fort P: TrioGEF1 controls Rac- and Cdc42-dependent cell structures through the direct activation of RhoG. J Cell Sci 2000, 113:729-739
26. Debant A, Serra-Pages C, Seipel K, O'Brien S, Tang M, Park SH, Streuli M: The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate Rac-specific and Rho-specific guanine nucleotide exchange factor domains. Proc Natl Acad Sci USA 1996, 93:5466-5471
27. Movilla N, Dosil M, Zheng Y, Bustelo XR: How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42. Oncogene 2001, 20:8057-8065
28. Schiller MR: Coupling receptor tyrosine kinases to Rho GTPases - GEFs what's the link. Cell Signal 2006, 18:1834-1843
29. Schmidt A, Hall A: Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002, 16:1587-1609
30. Oceguera-Yanez F, Kimura K, Yasuda S, Higashida C, Kitamura T, Hiraoka Y, Haraguchi T, Narumiya S: Ect2 and MgcRacGAP regulate the activation and function of Cdc42 in mitosis. J Cell Biol 2005, 168:221-232
31. Piekny A, Werner M, Glotzer M: Cytokinesis: welcome to the Rho zone. Trends Cell Biol 2005, 15:651-658
32. Yüce O, Piekny A, Glotzer M: An ECT2-central spindlin complex regulates the localization and function of RhoA. J Cell Biol 2005, 170:571-582
33. Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H, Rubin J, Miki T: Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains. J Cell Biochem 2003, 90:819-836
34. Liu XF, Ishida H, Raziuddin R, Miki T: Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity. Mol Cell Biol 2004, 24:6665-6675
35. Etienne-Manneville S, Hall A: Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 2001, 106:489-498
36. Liu XF, Ohno S, Miki T: Nucleotide exchange factor ECT2 regulates epithelial cell polarity. Cell Signal 2006, 18:1604-1615
37. Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, Miki T, Yamanaka R: Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep 2006, 16:1093-1098
38. Bateman J, Van Vactor D: The Trio family of guanine-nucleotide-exchange factors: regulators of axon guidance. J Cell Sci 2001, 114:1973-1980
39. deBakker CD, Haney LB, Kinchen JM, Grimsley C, Lu M, Klingele D, Hsu PK, Chou BK, Cheng LC, Blangy A, Sondek J, Hengartner MO, Wu YC, Ravichandran KS: Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO. Curr Biol 2004, 14:2208-2216
40. Henson PM: Engulfment: ingestion and migration with Rac, Rho and TRIO. Curr Biol 2005, 15:R29-R30
41. Lundquist EA, Reddien PW, Hartwieg E, Horvitz HR, Bargmann CI: Three C. elegans Rac proteins and several alternative Rac regulators control axon guidance, cell migration and apoptotic cell phagocytosis. Development 2001, 128:4475-4488
42. Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY: ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 2007, 67:7203-7211
43. Bustelo XR: Regulatory and signaling properties of the Vav family. Mol Cell Biol 2000, 20:1461-1477
44. Bustelo XR: Vav proteins, adaptors and cell signaling. Oncogene 2001, 20:6372-6381
45. Akbasak A, Sunar-Akbasak B: Oncogenes: cause or consequence in the development of glial tumors. J Neurol Sci 1992, 111:119-133
46. Louis DN, Gusella JF: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 1995, 11:412-415
47. Louis DN, Seizinger BR: Genetic basis of neurological tumours. Baillieres Clin Neurol 1994, 3:335-352
48. Zhu Y, Parada LF: The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002, 2:616-626
49. Fritz G, Just I, Kaina B: Rho GTPases are over-expressed in human tumors. Int J Cancer 1999, 81:682-687
50. Iwadate Y, Sakaida T, Saegusa T, Hiwasa T, Takiguchi M, Fujimoto S, Yamaura A: Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas. Int J Oncol 2005, 26:993-998
51. Yuan S, Miller DW, Barnett GH, Hahn JF, Williams BR: Identification and characterization of human beta 2-chimaerin: association with malignant transformation in astrocytoma. Cancer Res 1995, 55:3456-3461
52. Bos JL, Rehmann H, Wittinghofer A: GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007, 129:865-877
53. Fleming IN, Batty IH, Prescott AR, Gray A, Kular GS, Stewart H, Downes CP: Inositol phospholipids regulate the guanine-nucleotide-exchange factor Tiam1 by facilitating its binding to the plasma membrane and regulating GDP/GTP exchange on Rac1. Biochem J 2004, 382:857-865
54. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D: Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998, 279:558-560